Alterations in connexin 43 during diabetic cardiomyopathy: Competition of tyrosine nitration versus phosphorylation

Journal of Diabetes

Volumn 7, Issue 2, 2015, Pages 250-259

  Joshi, Mandar S ^a,b,e   Mihm, Michael J ^c   Cook, Angela C ^c   Schanbacher, Brandon L ^d,e   Bauer, John Anthony ^d,e  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c OHIO STATE UNIVERSITY   (United States)

^d THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cardiomyopathy; Connexins; Diabetes; Oxidative stress; Signal transduction

Indexed keywords

CONNEXIN 40; CONNEXIN 43; STREPTOZOCIN; TYROSINE; NITROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DISEASE COURSE; ELECTROCARDIOGRAPHY; GLYCEMIC CONTROL; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE CONDUCTION; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; NITRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QRS COMPLEX; QT INTERVAL; RAT; ANIMAL; COMPARATIVE STUDY; COMPLICATION; DIABETIC CARDIOMYOPATHIES; ELECTROPHYSIOLOGY; ENZYME IMMUNOASSAY; EXPERIMENTAL DIABETES MELLITUS; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CONNEXIN 43; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC CARDIOMYOPATHIES; ELECTROPHYSIOLOGY; HYPERGLYCEMIA; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; MALE; NITROGEN; OXIDATIVE STRESS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE;

EID: 84924120769     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12164     Document Type: Article

References (42)

1. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes. 1974; 23: 105-111.
2. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999; 281: 1291-1297.
3. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: The Framingham study. Am J Cardiol. 1974; 34: 29-34.
4. Pieske B, Wachter R. Impact of diabetes and hypertension on the heart. Curr Opin Cardiol. 2008; 23: 340-349.
5. Hayat SA, Patel B, Khattar RS, Malik RA. Diabetic cardiomyopathy: Mechanisms, diagnosis and treatment. Clin Sci. 2004; 107: 539-557.
6. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Prog Cardiovasc Dis. 1985; 27: 255-270.
7. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972; 30: 595-602.
8. Han B, Baliga R, Huang H, Giannone PJ, Bauer JA. Decreased cardiac expression of vascular endothelial growth factor and redox imbalance in murine diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2009; 297: H829-835.
9. Jarrett RJ. Cardiovascular disease and hypertension in diabetes mellitus. Diabetes Metab Rev. 1989; 5: 547-558.
10. Spector KS. Diabetic cardiomyopathy. Clin Cardiol. 1998; 21: 885-887.
11. Olson JC, Erbey JR, Williams KV etal. Subclinical atherosclerosis and estimated glucose disposal rate as predictors of mortality in type 1 diabetes. Ann Epidemiol. 2002; 12: 331-337.
12. Rossing P, Breum L, Major-Pedersen A etal. Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus. Diabet Med. 2001; 18: 199-205.
13. Howarth FC, Chandler NJ, Kharche S etal. Effects of streptozotocin-induced diabetes on connexin43 mRNA and protein expression in ventricular muscle. Mol Cell Biochem. 2008; 319: 105-114.
14. Saffitz JE, Davis LM, Darrow BJ, Kanter HL, Laing JG, Beyer EC. The molecular basis of anisotropy: Role of gap junctions. J Cardiovasc Electrophysiol. 1995; 6: 498-510.
15. Yeager M. Structure of cardiac gap junction intercellular channels. J Struct Biol. 1998; 121: 231-245.
16. Gourdie RG, Green CR, Severs NJ, Thompson RP. Immunolabelling patterns of gap junction connexins in the developing and mature rat heart. Anat Embryol. 1992; 185: 363-378.
17. Kirchhoff S, Kim JS, Hagendorff A etal. Abnormal cardiac conduction and morphogenesis in connexin40 and connexin43 double-deficient mice. Circ Res. 2000; 87: 399-405.
18. Lin H, Ogawa K, Imanaga I, Tribulova N. Remodeling of connexin 43 in the diabetic rat heart. Mol Cell Biochem. 2006; 290: 69-78.
19. Howarth FC, Nowotny N, Zilahi E, El Haj MA, Lei M. Altered expression of gap junction connexin proteins may partly underlie heart rhythm disturbances in the streptozotocin-induced diabetic rat heart. Mol Cell Biochem. 2007; 305: 145-151.
20. Sung PH, Sun CK, Ko SF etal. Impact of hyperglycemic control on left ventricular myocardium. A molecular and cellular basic study in a diabetic rat model. Int Heart J. 2009; 50: 191-206.
21. Laing JG, Tadros PN, Westphale EM, Beyer EC. Degradation of connexin43 gap junctions involves both the proteasome and the lysosome. Exp Cell Res. 1997; 236: 482-492.
22. Lampe PD, Lau AF. Regulation of gap junctions by phosphorylation of connexins. Arch Biochem Biophys. 2000; 384: 205-215.
23. Hunt JV, Wolff SP. Oxidative glycation and free radical production: A causal mechanism of diabetic complications. Free Radic Res Commun. 1991; 12-13: 115-123.
24. Fridericia LS. Die systolendauer im elektrokardiogramm bei normalen menschen und bei herzkranken. Acta Med Scand. 1920; 53: 469-486.
25. Mihm MJ, Coyle CM, Schanbacher BL, Weinstein DM, Bauer JA. Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc Res. 2001; 49: 798-807.
26. Mildenberger RR, Bar-Shlomo B, Druck MN etal. Clinically unrecognized ventricular dysfunction in young diabetic patients. J Am Coll Cardiol. 1984; 4: 234-238.
27. Paillole C, Dahan M, Paycha F, Solal AC, Passa P, Gourgon R. Prevalence and significance of left ventricular filling abnormalities determined by Doppler echocardiography in young type I (insulin-dependent) diabetic patients. Am J Cardiol. 1989; 64: 1010-1016.
28. Sanderson JE, Brown DJ, Rivellese A, Kohner E. Diabetic cardiomyopathy? An echocardiographic study of young diabetics. BMJ. 1978; 1: 404-407.
29. Dash H, Johnson RA, Dinsmore RE, Francis CK, Harthorne JW. Cardiomyopathic syndrome due to coronary arter disease. II: Increased prevalence in patients with diabetes mellitus: A matched pair analysis. Br Heart J. 1977; 39: 740-747.
30. Mihm MJ, Seifert JL, Coyle CM, Bauer JA. Diabetes related cardiomyopathy time dependent echocardiographic evaluation in an experimental rat model. Life Sci. 2001; 69: 527-542.
31. Gros D, Jarry-Guichard T, Ten Velde I etal. Restricted distribution of connexin40, a gap junctional protein, in mammalian heart. Circ Res. 1994; 74: 839-851.
32. Chaves AA, Dech SJ, Nakayama T, Hamlin RL, Bauer JA, Carnes CA. Age and anesthetic effects on murine electrocardiography. Life Sci. 2003; 72: 2401-2412.
33. Saffitz JE. Connexins, conduction, and atrial fibrillation. N Engl J Med. 2006; 354: 2712-2714.
34. Klotz LO, Schroeder P, Sies H. Peroxynitrite signaling: Receptor tyrosine kinases and activation of stress-responsive pathways. Free Radic Biol Med. 2002; 33: 737-743.
35. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol. 1996; 271: C1424-1437.
36. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol. 1996; 9: 836-844.
37. Ischiropoulos H. Biological tyrosine nitration: A pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys. 1998; 356: 1-11.
38. Mihm MJ, Yu F, Carnes CA etal. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. 2001; 104: 174-180.
39. Mihm MJ, Yu F, Weinstein DM, Reiser PJ, Bauer JA. Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: Evidence for selective impairment of myofibrillar creatine kinase. Br J Pharmacol. 2002; 135: 581-588.
40. Turko IV, Murad F. Protein nitration in cardiovascular diseases. Pharmacol Rev. 2002; 54: 619-634.
41. Yeo WS, Lee SJ, Lee JR, Kim KP. Nitrosative protein tyrosine modifications: Biochemistry and functional significance. BMB Rep. 2008; 41: 194-203.
42. Monteiro HP, Arai RJ, Travassos LR. Protein tyrosine phosphorylation and protein tyrosine nitration in redox signaling. Antioxid Redox Signal. 2008; 10: 843-889.